MAY 16, 2019
Comprehensive Ophthalmology, Glaucoma, Medical Therapy, Uveitis
In this 1-Minute video, Dr. Tosin Smith offers pearls for identifying, managing and avoiding brimonidine-induced uveitis and conjunctivitis. Although brimonidine is a relatively common IOP-lowering agent, some patients develop redness, foreign-body sensations and irritation. When patients present with granulomatous-type uveitis in the anterior chamber, she suggests physicians stop brimonidine therapy and switch patients to low-dose steroids. To avoid this complication, she recommends making sure patients do not have a brimonidine allergy before prescribing the drug, and beginning with a low dose.
Relevant Financial Disclosures: None